The next board meeting for Nurix Therapeutics Inc is on 28 Jan 2026 for the purpose of Nurix Therapeutics Inc Fourth Quarter Earnings Results for 2025See details
Nurix Therapeutics Inc has a share price target of US$ 30, revenue growth forecast of 56.2%, and profit growth estimate of -40.0% for FY25, based on top 17 analyst calls.